http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 24 Aug 2026 08:03:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Azenta%2C+Inc.++++++++++++++For%3A+Aug+22/26964479.html si-local-file:///var/storage/secattach/20260824/26964479.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Azenta%2C+Inc.++++++++++++++For%3A+Aug+22/26964479.html Mon, 24 Aug 2026 08:03:00 -0400 AZTA O.00162109 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Azenta%2C+Inc.++++++++++++++For%3A+Aug+22/26964479.html si-local-file:///var/storage/secattach/20260824/26964479.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Azenta%2C+Inc.++++++++++++++For%3A+Aug+22/26964479.html Mon, 24 Aug 2026 08:03:00 -0400 AZTA O.00162109 http://www.streetinsider.com/Corporate+News/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html <p>Azenta, Inc. (Nasdaq: AZTA) announced that John Marotta has resigned as president, CEO, and director, and that board member Dr. Martin Madaus has been appointed interim president and CEO, according to a company press release dated Aug. 24, 2026.</p><p>Dr. Madaus has served on the Azenta board since 2024 and is a Senior Operating Executive at the Carlyle Group Inc. (Nasdaq: CG). He has previously held CEO roles at Millipore Corporation, Ortho-Clinical Diagnostics, and Roche Diagnostics North America.</p><p>The company said it has retained search firm Heidrick & Struggles to conduct a permanent CEO search.</p><p>Azenta reaffirmed its previously issued fourth quarter fiscal http://www.streetinsider.com/Corporate+News/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html Mon, 24 Aug 2026 08:01:03 -0400 AZTA CG HAE ROG http://www.streetinsider.com/Corporate+News/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html <p>Azenta, Inc. (Nasdaq: AZTA) announced that John Marotta has resigned as president, CEO, and director, and that board member Dr. Martin Madaus has been appointed interim president and CEO, according to a company press release dated Aug. 24, 2026.</p><p>Dr. Madaus has served on the Azenta board since 2024 and is a Senior Operating Executive at the Carlyle Group Inc. (Nasdaq: CG). He has previously held CEO roles at Millipore Corporation, Ortho-Clinical Diagnostics, and Roche Diagnostics North America.</p><p>The company said it has retained search firm Heidrick & Struggles to conduct a permanent CEO search.</p><p>Azenta reaffirmed its previously issued fourth quarter fiscal http://www.streetinsider.com/Corporate+News/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html Mon, 24 Aug 2026 08:01:03 -0400 AZTA CG HAE ROG http://www.streetinsider.com/Corporate+News/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html <p>Azenta, Inc. (Nasdaq: AZTA) announced that John Marotta has resigned as president, CEO, and director, and that board member Dr. Martin Madaus has been appointed interim president and CEO, according to a company press release dated Aug. 24, 2026.</p><p>Dr. Madaus has served on the Azenta board since 2024 and is a Senior Operating Executive at the Carlyle Group Inc. (Nasdaq: CG). He has previously held CEO roles at Millipore Corporation, Ortho-Clinical Diagnostics, and Roche Diagnostics North America.</p><p>The company said it has retained search firm Heidrick & Struggles to conduct a permanent CEO search.</p><p>Azenta reaffirmed its previously issued fourth quarter fiscal http://www.streetinsider.com/Corporate+News/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html Mon, 24 Aug 2026 08:01:03 -0400 AZTA CG HAE ROG http://www.streetinsider.com/Corporate+News/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html <p>Azenta, Inc. (Nasdaq: AZTA) announced that John Marotta has resigned as president, CEO, and director, and that board member Dr. Martin Madaus has been appointed interim president and CEO, according to a company press release dated Aug. 24, 2026.</p><p>Dr. Madaus has served on the Azenta board since 2024 and is a Senior Operating Executive at the Carlyle Group Inc. (Nasdaq: CG). He has previously held CEO roles at Millipore Corporation, Ortho-Clinical Diagnostics, and Roche Diagnostics North America.</p><p>The company said it has retained search firm Heidrick & Struggles to conduct a permanent CEO search.</p><p>Azenta reaffirmed its previously issued fourth quarter fiscal http://www.streetinsider.com/Corporate+News/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html Mon, 24 Aug 2026 08:01:03 -0400 AZTA CG HAE ROG http://www.streetinsider.com/Management+Changes/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html <p>Azenta, Inc. (Nasdaq: AZTA) announced that John Marotta has resigned as president, CEO, and director, and that board member Dr. Martin Madaus has been appointed interim president and CEO, according to a company press release dated Aug. 24, 2026.</p><p>Dr. Madaus has served on the Azenta board since 2024 and is a Senior Operating Executive at the Carlyle Group Inc. (Nasdaq: CG). He has previously held CEO roles at Millipore Corporation, Ortho-Clinical Diagnostics, and Roche Diagnostics North America.</p><p>The company said it has retained search firm Heidrick & Struggles to conduct a permanent CEO search.</p><p>Azenta reaffirmed its previously issued fourth quarter fiscal http://www.streetinsider.com/Management+Changes/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html Mon, 24 Aug 2026 08:01:03 -0400 AZTA CG HAE ROG http://www.streetinsider.com/Management+Changes/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html <p>Azenta, Inc. (Nasdaq: AZTA) announced that John Marotta has resigned as president, CEO, and director, and that board member Dr. Martin Madaus has been appointed interim president and CEO, according to a company press release dated Aug. 24, 2026.</p><p>Dr. Madaus has served on the Azenta board since 2024 and is a Senior Operating Executive at the Carlyle Group Inc. (Nasdaq: CG). He has previously held CEO roles at Millipore Corporation, Ortho-Clinical Diagnostics, and Roche Diagnostics North America.</p><p>The company said it has retained search firm Heidrick & Struggles to conduct a permanent CEO search.</p><p>Azenta reaffirmed its previously issued fourth quarter fiscal http://www.streetinsider.com/Management+Changes/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html Mon, 24 Aug 2026 08:01:03 -0400 AZTA CG HAE ROG http://www.streetinsider.com/Management+Changes/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html <p>Azenta, Inc. (Nasdaq: AZTA) announced that John Marotta has resigned as president, CEO, and director, and that board member Dr. Martin Madaus has been appointed interim president and CEO, according to a company press release dated Aug. 24, 2026.</p><p>Dr. Madaus has served on the Azenta board since 2024 and is a Senior Operating Executive at the Carlyle Group Inc. (Nasdaq: CG). He has previously held CEO roles at Millipore Corporation, Ortho-Clinical Diagnostics, and Roche Diagnostics North America.</p><p>The company said it has retained search firm Heidrick & Struggles to conduct a permanent CEO search.</p><p>Azenta reaffirmed its previously issued fourth quarter fiscal http://www.streetinsider.com/Management+Changes/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html Mon, 24 Aug 2026 08:01:03 -0400 AZTA CG HAE ROG http://www.streetinsider.com/Management+Changes/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html <p>Azenta, Inc. (Nasdaq: AZTA) announced that John Marotta has resigned as president, CEO, and director, and that board member Dr. Martin Madaus has been appointed interim president and CEO, according to a company press release dated Aug. 24, 2026.</p><p>Dr. Madaus has served on the Azenta board since 2024 and is a Senior Operating Executive at the Carlyle Group Inc. (Nasdaq: CG). He has previously held CEO roles at Millipore Corporation, Ortho-Clinical Diagnostics, and Roche Diagnostics North America.</p><p>The company said it has retained search firm Heidrick & Struggles to conduct a permanent CEO search.</p><p>Azenta reaffirmed its previously issued fourth quarter fiscal http://www.streetinsider.com/Management+Changes/Azenta+names+board+member+as+interim+CEO+after+Marotta+resigns/26964448.html Mon, 24 Aug 2026 08:01:03 -0400 AZTA CG HAE ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/Press+Releases/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/PRNewswire/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/PRNewswire/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/PRNewswire/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/PRNewswire/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/PRNewswire/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/PRNewswire/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG http://www.streetinsider.com/PRNewswire/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html <div class="xn-content"> <p class="prntac"><i>Current Director Dr. Martin Madaus Appointed Interim CEO</i></p><p class="prntac"><i>Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 24, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA) ("<span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta</span>" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. <person>Martin Madaus</person> has been appointed interim President and CEO, and that <person>John Marotta</person> has resigned as an executive officer and director of the Company.</p><p><person>Dr. Madaus</person> has served in multiple CEO roles in the diagnostics and life science tools industry and joined http://www.streetinsider.com/PRNewswire/AZENTA+ANNOUNCES+LEADERSHIP+TRANSITION/26964377.html Mon, 24 Aug 2026 08:00:00 -0400 A.39767288 A.50201100 AZTA CG HAE O.00003373 O.00038634 O.00085816 O.00162109 O.02747122 ROG